These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2318584)

  • 21. Absence of degenerative changes in retinal and uveal capillary pericytes in diabetic rats.
    Tilton RG; LaRose LS; Kilo C; Williamson JR
    Invest Ophthalmol Vis Sci; 1986 May; 27(5):716-21. PubMed ID: 3700020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age-related thickening of retinal capillary basement membranes.
    Nagata M; Katz ML; Robison WG
    Invest Ophthalmol Vis Sci; 1986 Mar; 27(3):437-40. PubMed ID: 3949472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fenestrated subendothelial basement membranes in human retinal capillaries.
    Carlson EC
    Invest Ophthalmol Vis Sci; 1989 Sep; 30(9):1923-32. PubMed ID: 2777512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remodeling of retinal capillaries in the diabetic hypertensive rat.
    Dosso AA; Leuenberger PM; Rungger-Brändle E
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2405-10. PubMed ID: 10476809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasminogen activator inhibitor (PAI)-1 overexpression in retinal microvessels of PAI-1 transgenic mice.
    Grant MB; Spoerri PE; Player DW; Bush DM; Ellis EA; Caballero S; Robison WG
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2296-302. PubMed ID: 10892876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. -to: Gardiner TA, Anderson HR, Degenhardt T et al. (2003) prevention of retinal capillary basement membrane thickening in diabetic dogs by a non-steroidal anti-inflammatory drug. Diabetologia 46:1269-1275.
    Biswas SK; Lopes de Faria JB; Lopes de Faria JM
    Diabetologia; 2004 Apr; 47(4):763. PubMed ID: 15298359
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of aldose reductase inhibitor on retinal microangiopathy in streptozotocin-diabetic rats.
    Kojima K; Matsubara H; Harada T; Mizuno K; Suzuki M; Hotta N; Kakuta H; Sakamoto N
    Jpn J Ophthalmol; 1985; 29(1):99-109. PubMed ID: 3159927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microvascular retinopathy in the Zucker diabetic fatty rat.
    Danis RP; Yang Y
    Invest Ophthalmol Vis Sci; 1993 Jun; 34(7):2367-71. PubMed ID: 8505219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinal capillary pericyte apoptosis in early human diabetic retinopathy.
    Li W; Yanoff M; Liu X; Ye X
    Chin Med J (Engl); 1997 Sep; 110(9):659-63. PubMed ID: 9642318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic-like retinopathy: early and late intervention therapies in galactose-fed rats.
    Robison WG; Jacot JL; Glover JP; Basso MD; Hohman TC
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1933-41. PubMed ID: 9727416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
    Kern TS; Tang J; Mizutani M; Kowluru RA; Nagaraj RH; Romeo G; Podesta F; Lorenzi M
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrastructural alterations in capillaries of the diabetic hypertensive rat retina: protective effects of ACE inhibition.
    Dosso AA; Rungger-Brändle E; Leuenberger PM
    Diabetologia; 2004 Jul; 47(7):1196-1201. PubMed ID: 15243702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes-related histopathologies of the rat retina prevented with an aldose reductase inhibitor.
    Robison WG; Tillis TN; Laver N; Kinoshita JH
    Exp Eye Res; 1990 Apr; 50(4):355-66. PubMed ID: 2110907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrastructural features of retinal capillary basement membrane thickening in diabetic swine.
    Lee SE; Ma W; Rattigan EM; Aleshin A; Chen L; Johnson LL; D'Agati VD; Schmidt AM; Barile GR
    Ultrastruct Pathol; 2010 Feb; 34(1):35-41. PubMed ID: 20070152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of treatment after measurable diabeticlike retinopathy in galactose-fed rats.
    Robison WG; Laver NM; Jacot JL; Chandler ML; York BM; Glover JP
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1066-73. PubMed ID: 9152226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the size of pericytes of the retinal capillaries in the normal and diabetic state.
    Fisher RF
    Trans Ophthalmol Soc U K (1962); 1980 Apr; 100(Pt 1):90-5. PubMed ID: 6943839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-peptide and retinal microangiopathy in diabetes.
    Chakrabarti S; Khan ZA; Cukiernik M; Zhang W; Sima AA
    Exp Diabesity Res; 2004; 5(1):91-6. PubMed ID: 15198374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy.
    Zhang JZ; Xi X; Gao L; Kern TS
    Curr Eye Res; 2007 Oct; 32(10):883-9. PubMed ID: 17963108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Increased capillary vulnerability in diabetic retinopathy].
    Fuchs U; Tinius W; Gonschorek S; vom Scheidt J
    Klin Monbl Augenheilkd; 1988 Mar; 192(3):234-6. PubMed ID: 3374013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basement-membrane thickening and diabetic microangiopathy.
    Williamson JR; Kilo C
    Diabetes; 1976; 25(2 SUPPL):925-7. PubMed ID: 786763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.